Elonox Logo
Person Smiling Person Smiling

ELONOX® and ELONOX® HP are a biosimilar option to LOVENOX® and LOVENOX® HP1,2.

Covered in all provinces, including Ontario
(criteria may apply)*

*Special Authorization required in BC, SK, MB, and NFLD.

KabiCare Patient KabiCare Patient

ELONOX® is backed by the KabiCare Patient Support Program

KabiCare Patient Support program from Fresenius Kabi
Simple enrolment

Simple enrolment

Reimbursement support

Reimbursement support

Financial assistance

Financial assistance

Injection training materials

Injection training materials

Dedicated call centre

Dedicated call centre

First-dose sampling program**

First-dose sampling program**

** Available at select partner sites only. First dose supply varies by clinic.

For Patient Support Program services:

References:

  • 1. ELONOX® and ELONOX® HP Product Monograph. Fresenius Kabi Canada Ltd. October 26, 2022.
  • 2. LOVENOX® Product Monograph. Sanofi Aventis Canada, Inc. September 7, 2021.